becton-dickinson-nexiva-single-catheter

Register to receive a free European Markets Report Suite for Vascular Access Devices and Accessories report synopsis and brochure

According to a new series of reports on the European markets for vascular access devices by iData Research, Europe-wide legislation promoting the use of safety devices such as syringes and needles in the workplace has resulted in market growth. Safety products carry a significant price premium compared to conventional products. The higher average selling prices (ASPs) of these safety devices have increased the value of the market and ongoing conversion to these products is expected to boost future growth. While the transition to the use of safety needles and PIVCs is taking place in Europe following the introduction of the directive by the Council of the European Union, lack of enforcement by local authorities will ultimately hinder the transition to safety devices.

“The largest vascular access device segment in Europe is the syringe and needle market, driven by increases in the various safety needle and safety syringe sub-segments,” explains Dr. Kamran Zamanian, CEO of iData. “This market is expected to increase in value to reach nearly €650 million by 2023.”

The European market for manufactured catheter securement devices (MCSDs) is the fastest growing segment in the total European vascular access market. The MCSD segment is growing as a result of reimbursement cessation for catheter-related infections. Additionally, MCSDs are becoming a larger portion of the total securement market, as they sell at a higher price than traditional dressings and sutures.

Becton Dickinson is the leading competitor in the European vascular access device and accessories market. The company has a strong presence in the high value peripheral intravenous catheter (PIVC) and syringe and needle markets. PIVCs and syringe and needle products use similar components, which enables Becton Dickinson to establish multiple manufacturing plants all over the world. They have the strongest market share in the Beneluxian and Spanish markets.

Becton Dickinson’s safety products include the ported Venflon™ and the straight Insyte™ Autoguard™ devices. Becton Dickinson also has two closed system PIVCs: the Saf-T-Intima™ and the Nexiva™ product lines. These closed system PIVCs are advanced and high priced safety devices. As a result, these devices will increase Becton Dickinson’s market revenues as more of them are sold in Europe. However, Becton Dickinson is experiencing increasing competition from B. Braun, Terumo and Smiths Medical which have greater price flexibility.

B. Braun is the second leading competitor in the European market and holds a substantial presence in the same markets as Becton Dickinson. The company has been drastically lowering prices of safety PIVCs in order to gain market share. In some cases, it has been selling its safety products at a similar price to its conventional catheters. The company has benefited by having its headquarters located in Germany, and its strong presence there and in neighboring markets is expected to continue in the future.

For Further Information
More on the vascular access device market in Europe can be found in a series of reports published by iData Research entitled the European Markets Report Suite for Vascular Access Devices and Accessories.